|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:dexlansoprazole
|
|
gptkbp:approvalYear
|
2009
|
|
gptkbp:ATCCode
|
A02BC06
|
|
gptkbp:availableOn
|
gptkb:Canada
gptkb:Europe
gptkb:Japan
gptkb:United_States
|
|
gptkbp:CASNumber
|
138530-94-6
|
|
gptkbp:chemicalFormula
|
C16H14F3N3O2S
|
|
gptkbp:contraindication
|
hypersensitivity to dexlansoprazole
|
|
gptkbp:drugClass
|
proton pump inhibitor
|
|
gptkbp:eliminationHalfLife
|
1-2 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:form
|
delayed-release capsule
|
|
gptkbp:formerName
|
gptkb:Kapidex
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dexilant
|
|
gptkbp:legalStatus
|
Rx-only (US)
|
|
gptkbp:manufacturer
|
gptkb:Takeda_Pharmaceutical_Company
|
|
gptkbp:mechanismOfAction
|
inhibits gastric acid secretion
|
|
gptkbp:metabolism
|
liver (CYP2C19, CYP3A4)
|
|
gptkbp:pregnancyCategory
|
Category B (US)
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
diarrhea
abdominal pain
upper respiratory tract infection
|
|
gptkbp:usedFor
|
gptkb:erosive_esophagitis
gptkb:gastroesophageal_reflux_disease
|
|
gptkbp:bfsParent
|
gptkb:Takeda
gptkb:Takeda_(Japan)
|
|
gptkbp:bfsLayer
|
6
|